Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-17 Purchase |
2022-05-19 6:11 pm |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
2,000 | $1.5945 | $3,189 | 433,390 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-31 Exercise |
2023-01-04 5:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
18,208 | $0 | 59,477 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 5:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
30,000 | $0 | 59,477 (Direct) |
View |
| 2022-08-05 Exercise(A) |
2023-01-04 5:29 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
1,169 | $0 | 547,448 (Direct) |
View |
| 2022-10-06 Tax Withholding |
2022-10-11 09:35 am |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
4,163 | $0 | 162,061 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-11 09:35 am |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
12,500 | $0 | 162,061 (Direct) |
View |
| 2022-09-30 Option Award(A) |
2022-10-05 4:40 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
12,950 | $0 | 339,663 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:57 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
10,850 | $0 | 333,680 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:55 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
10,850 | $0 | 333,680 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:55 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
13,850 | $0 | 342,227 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:52 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
10,850 | $0 | 333,680 (Direct) |
View |
| 2022-06-30 Option Award |
2022-10-03 4:51 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
23,947 | $0 | 326,713 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:48 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
25,350 | $0 | 374,993 (Direct) |
View |
| 2022-08-16 Gift |
2022-08-23 4:34 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
7,000 | $0 | 130,275 (Direct) |
View |
| 2022-08-16 Gift |
2022-08-23 4:30 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
9,250 | $0 | 1,683,447 (Direct) |
View |
| 2022-03-31 Option Award |
2022-08-09 4:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
4,393 | $0 | 546,279 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:29 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
1,169 | $0 | 11,269 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
7,601 | $0 | 49,250 (Direct) |
View |
| 2022-08-05 Tax Withholding |
2022-08-09 4:28 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
2,462 | $3.17 | 49,250 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:26 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
7,601 | $0 | 1,692,697 (Direct) |
View |
| 2022-08-05 Tax Withholding |
2022-08-09 4:26 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
2,531 | $3.17 | 1,692,697 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:25 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
7,601 | $0 | 536,372 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:23 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
7,601 | $0 | 354,437 (Direct) |
View |
| 2021-08-05 Tax Withholding |
2022-08-09 4:23 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
1,782 | $3.17 | 354,437 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:22 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
7,601 | $0 | 438,335 (Direct) |
View |
| 2022-08-05 Tax Withholding |
2022-08-09 4:22 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
2,656 | $3.17 | 438,335 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:20 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
1,169 | $0 | 98,698 (Direct) |
View |
| 2022-07-19 Option Award |
2022-07-21 4:46 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Neal James R Director |
17,797 | $0 | 17,797 (Direct) |
View |
| 2022-07-12 Option Award |
2022-07-14 4:24 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director |
19,091 | $0 | 19,091 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:42 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
20,064 | $0 | 322,830 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:41 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
25,611 | $0 | 328,377 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:40 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
20,064 | $0 | 322,830 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:37 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
20,064 | $0 | 322,830 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:35 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
23,947 | $0 | 326,713 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
46,877 | $0 | 349,643 (Direct) |
View |
| 2022-01-01 Option Award |
2022-04-19 9:21 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
18,208 | $0 | 19,377 (Direct) |
View |
| 2022-01-01 Option Award |
2022-04-19 9:20 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
18,208 | $0 | 19,377 (Direct) |
View |
| 2022-01-01 Option Award |
2022-04-19 9:17 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
18,208 | $0 | 19,377 (Direct) |
View |
| 2022-01-01 Option Award |
2022-04-19 9:15 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Islam Khalid Director |
18,208 | $0 | 18,208 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-11 6:00 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
247,841 | $0 | 302,766 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-11 5:58 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
247,841 | $0 | 302,766 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-11 5:56 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
247,841 | $0 | 302,766 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-11 5:54 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
247,841 | $0 | 302,766 (Direct) |
View |